Literature DB >> 3534094

Use of monoclonal antibodies to quantify subclasses of human IgG. I. Development of two-site immunoenzymometric assays for total IgG subclass determinations.

R Hussain, R W Poindexter, R Wistar, C B Reimer.   

Abstract

Dissection of the IgG antibody response into its subclass components has been difficult largely because of the lack of adequate supplies of specific reagents. The development of monoclonal antibodies (Mcab) promises to overcome this problem, but the use of such antibodies has certain inherent problems. It has been shown recently that Mcabs which were avid, potent and specific for well defined epitopes may partially or completely lose their activity depending on the assay system in which they were used. In order to identify Mcabs that would be specific and useful as capture antibodies in a simple two-site enzymometric assay, a panel of 18 Mcabs was screened and one Mcab to each of the four IgG subclasses was identified for quantitation of subclass levels in human serum.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3534094     DOI: 10.1016/0022-1759(86)90437-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  15 in total

1.  Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis.

Authors:  R Hussain; H Shiratsuchi; M Phillips; J Ellner; R S Wallis
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination.

Authors:  K R Lottenbach; C M Mink; S J Barenkamp; E L Anderson; S M Homan; D C Powers
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Selective correlation of interferon-gamma, tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor with immunoglobulin G1 and immunoglobulin G3 subclass antibody in leprosy.

Authors:  R Hussain; A Kifayet; M Dojki; H M Dockrell
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

Review 4.  Selective IgG subclass deficiency: quantification and clinical relevance.

Authors:  R Jefferis; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

5.  Dominant recognition of a cross-reactive B-cell epitope in Mycobacterium leprae 10 K antigen by immunoglobulin G1 antibodies across the disease spectrum in leprosy.

Authors:  R Hussain; H M Dockrell; T J Chiang
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

6.  Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma.

Authors:  C L King; J I Gallin; H L Malech; S L Abramson; T B Nutman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  Immunoglobulin G subclass preference of intrathecally produced HIV-specific oligoclonal antibodies.

Authors:  R Kaiser; R Dörries; B Ruf; H D Pohle; R Martin; V ter Meulen
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

8.  Selective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients.

Authors:  R Hussain; G Dawood; N Abrar; Z Toossi; A Minai; M Dojki; J J Ellner
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

9.  Subclass distribution of human IgG autoantibodies in pemphigus.

Authors:  C C Jones; R G Hamilton; R E Jordon
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

10.  Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection.

Authors:  J Huskinson; P N Stepick-Biek; F G Araujo; P Thulliez; Y Suzuki; J S Remington
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.